Antibiotics (May 2020)

New Insights into Bioactive Compounds from the Medicinal Plant <i>Spathodea campanulata</i> P. Beauv. and Their Activity against <i>Helicobacter pylori</i>

  • Corinne Raïssa Ngnameko,
  • Lucia Marchetti,
  • Barbara Zambelli,
  • Antonio Quotadamo,
  • Davide Roncarati,
  • Davide Bertelli,
  • Frederic Nico Njayou,
  • Stella I. Smith,
  • Paul F. Moundipa,
  • Maria Paola Costi,
  • Federica Pellati

DOI
https://doi.org/10.3390/antibiotics9050258
Journal volume & issue
Vol. 9, no. 5
p. 258

Abstract

Read online

The medicinal plant Spathodea campanulata P. Beauv. (Bignoniaceae) has been traditionally applied for the prevention and treatment of diseases of the kidney and urinary system, the skin, the gastrointestinal tract, and inflammation in general. The present work shows for the first time how chemical components from this plant inhibit Helicobacter pylori growth by urease inhibition and modulation of virulence factors. The crude extract and the main fractions of S. campanulata bark were tested on H. pylori isolated strains and the active ones were further fractionated. Fractions and sub-fractions of the plant crude extract were characterized by ultra-high-performance liquid chromatographic tandem high resolution-mass spectrometry detection (UHPLC-HRMS). Several phenolics and triterpenoids were identified. Among the sub-fractions obtained, SB2 showed the capacity to inhibit H. pylori urease in a heterologous bacterial model. One additional sub-fraction (SE3) was able to simultaneously modulate the expression of two adhesins (HopZ and BabA) and one cytotoxin (CagA). The flavonol kaempferol was identified as the most interesting compound that deserves further investigation as a new hit for its capacity to modulate H. pylori virulence factors.

Keywords